Standard
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes. / Engelen, Lian; Lund, Søren S; Ferreira, Isabel; Tarnow, Lise; Parving, Hans-Henrik; Gram, Jørgen; Hansen, Kaj Flemming Winther; Pedersen, Oluf; Teerlink, Tom; Barto, Rob; Stehouwer, Coen D A; Vaag, Allan A; Schalkwijk, Casper G.
I:
European Journal of Endocrinology, Bind 164, Nr. 3, 2011, s. 371-9.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Engelen, L, Lund, SS, Ferreira, I, Tarnow, L, Parving, H-H, Gram, J
, Hansen, KFW, Pedersen, O, Teerlink, T, Barto, R, Stehouwer, CDA
, Vaag, AA & Schalkwijk, CG 2011, '
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes',
European Journal of Endocrinology, bind 164, nr. 3, s. 371-9.
https://doi.org/10.1530/EJE-10-0851APA
Engelen, L., Lund, S. S., Ferreira, I., Tarnow, L., Parving, H-H., Gram, J.
, Hansen, K. F. W., Pedersen, O., Teerlink, T., Barto, R., Stehouwer, C. D. A.
, Vaag, A. A., & Schalkwijk, C. G. (2011).
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.
European Journal of Endocrinology,
164(3), 371-9.
https://doi.org/10.1530/EJE-10-0851Vancouver
Engelen L, Lund SS, Ferreira I, Tarnow L, Parving H-H, Gram J o.a.
Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes.
European Journal of Endocrinology. 2011;164(3):371-9.
https://doi.org/10.1530/EJE-10-0851Author
Engelen, Lian ; Lund, Søren S ; Ferreira, Isabel ; Tarnow, Lise ; Parving, Hans-Henrik ; Gram, Jørgen ; Hansen, Kaj Flemming Winther ; Pedersen, Oluf ; Teerlink, Tom ; Barto, Rob ; Stehouwer, Coen D A ; Vaag, Allan A ; Schalkwijk, Casper G. / Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes. I: European Journal of Endocrinology. 2011 ; Bind 164, Nr. 3. s. 371-9.
Bibtex
@article{6872c927ff2543b4aaee9c59db215a87,
title = "Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes",
abstract = "Metformin has been reported to reduce a-dicarbonyls, which are known to contribute to diabetic complications. It is unclear whether this is due to direct quenching of a-dicarbonyls or to an improvement in glycemic control. We therefore compared the effects of metformin versus repaglinide, an antihyperglycemic agent with an insulin-secreting mechanism, on the levels of the a-dicarbonyl 3-deoxyglucosone (3DG).",
keywords = "Carbamates, Confidence Intervals, Deoxyglucose, Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Metformin, Piperidines",
author = "Lian Engelen and Lund, {S{\o}ren S} and Isabel Ferreira and Lise Tarnow and Hans-Henrik Parving and J{\o}rgen Gram and Hansen, {Kaj Flemming Winther} and Oluf Pedersen and Tom Teerlink and Rob Barto and Stehouwer, {Coen D A} and Vaag, {Allan A} and Schalkwijk, {Casper G}",
year = "2011",
doi = "10.1530/EJE-10-0851",
language = "English",
volume = "164",
pages = "371--9",
journal = "European Journal of Endocrinology",
issn = "0804-4643",
publisher = "BioScientifica Ltd.",
number = "3",
}
RIS
TY - JOUR
T1 - Improved glycemic control induced by both metformin and repaglinide is associated with a reduction in blood levels of 3-deoxyglucosone in nonobese patients with type 2 diabetes
AU - Engelen, Lian
AU - Lund, Søren S
AU - Ferreira, Isabel
AU - Tarnow, Lise
AU - Parving, Hans-Henrik
AU - Gram, Jørgen
AU - Hansen, Kaj Flemming Winther
AU - Pedersen, Oluf
AU - Teerlink, Tom
AU - Barto, Rob
AU - Stehouwer, Coen D A
AU - Vaag, Allan A
AU - Schalkwijk, Casper G
PY - 2011
Y1 - 2011
N2 - Metformin has been reported to reduce a-dicarbonyls, which are known to contribute to diabetic complications. It is unclear whether this is due to direct quenching of a-dicarbonyls or to an improvement in glycemic control. We therefore compared the effects of metformin versus repaglinide, an antihyperglycemic agent with an insulin-secreting mechanism, on the levels of the a-dicarbonyl 3-deoxyglucosone (3DG).
AB - Metformin has been reported to reduce a-dicarbonyls, which are known to contribute to diabetic complications. It is unclear whether this is due to direct quenching of a-dicarbonyls or to an improvement in glycemic control. We therefore compared the effects of metformin versus repaglinide, an antihyperglycemic agent with an insulin-secreting mechanism, on the levels of the a-dicarbonyl 3-deoxyglucosone (3DG).
KW - Carbamates
KW - Confidence Intervals
KW - Deoxyglucose
KW - Diabetes Mellitus, Type 2
KW - Humans
KW - Hypoglycemic Agents
KW - Metformin
KW - Piperidines
U2 - 10.1530/EJE-10-0851
DO - 10.1530/EJE-10-0851
M3 - Journal article
C2 - 21205874
VL - 164
SP - 371
EP - 379
JO - European Journal of Endocrinology
JF - European Journal of Endocrinology
SN - 0804-4643
IS - 3
ER -
